Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (5): 434-439.DOI: 10.3969/j.issn.1673-8640.2020.05.008
Previous Articles Next Articles
SONG Yunxiao1, HUANG Xiaofeng1, ZHANG Haichen2(), YAO Tianyue1, YUAN Wenhua1, ZHAO Zhiyun1
Received:
2019-12-18
Online:
2020-05-30
Published:
2020-06-17
CLC Number:
SONG Yunxiao, HUANG Xiaofeng, ZHANG Haichen, YAO Tianyue, YUAN Wenhua, ZHAO Zhiyun. Correlations of serum IL-1,IL-2,IL-6,IL-8,IL-10 and hs-CRP levels with neovascularization glaucoma[J]. Laboratory Medicine, 2020, 35(5): 434-439.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.05.008
组别 | 例数 | 糖尿病史/例(%) | 高血压史/例(%) | 收缩压/kPa | 舒张压/kPa | BMI/(kg/m2) |
---|---|---|---|---|---|---|
正常对照组 | 39 | 12(30.77) | 22(56.41) | 17.52±2.24 | 9.86±2.05 | 23.63±3.07 |
NVG组 | 69 | 48(69.57)* | 38(55.07) | 17.69±2.36 | 10.17±1.82 | 24.33±3.22 |
组别 | 例数 | 糖尿病史/例(%) | 高血压史/例(%) | 收缩压/kPa | 舒张压/kPa | BMI/(kg/m2) |
---|---|---|---|---|---|---|
正常对照组 | 39 | 12(30.77) | 22(56.41) | 17.52±2.24 | 9.86±2.05 | 23.63±3.07 |
NVG组 | 69 | 48(69.57)* | 38(55.07) | 17.69±2.36 | 10.17±1.82 | 24.33±3.22 |
组别 | 例数 | IL-1/ (pg/mL) | IL-2/ (pg/mL) | IL-6/ (pg/mL) | IL-8/ (pg/mL) | IL-10/ (pg/mL) | hs-CRP/ (mg/L) |
---|---|---|---|---|---|---|---|
正常对照组 | 39 | 5.00±0.02 | 389.15±120.72 | 2.22±0.37 | 8.0(7.0~12.0) | 5.05±0.32 | 0.60(0.33~0.99) |
NVG组 | 69 | 5.34±1.47 | 430.95±172.76 | 3.52±2.61** | 23.0(13.5~167.0)** | 5.16±1.28 | 1.09(0.68~2.64)* |
组别 | 例数 | IL-1/ (pg/mL) | IL-2/ (pg/mL) | IL-6/ (pg/mL) | IL-8/ (pg/mL) | IL-10/ (pg/mL) | hs-CRP/ (mg/L) |
---|---|---|---|---|---|---|---|
正常对照组 | 39 | 5.00±0.02 | 389.15±120.72 | 2.22±0.37 | 8.0(7.0~12.0) | 5.05±0.32 | 0.60(0.33~0.99) |
NVG组 | 69 | 5.34±1.47 | 430.95±172.76 | 3.52±2.61** | 23.0(13.5~167.0)** | 5.16±1.28 | 1.09(0.68~2.64)* |
组别 | 例数 | IL-1/ (pg/mL) | IL-2/ (pg/mL) | IL-6/ (pg/mL) | IL-8/ (pg/mL) | IL-10/ (pg/mL) | hs-CRP/ (mg/L) |
---|---|---|---|---|---|---|---|
DR继发性NVG组 | 37 | 5.22±1.20 | 402.10±147.54 | 3.25±2.52 | 21.5(13.3~144.5) | 5.09±0.52 | 1.05(0.68~2.67) |
RVO继发性NVG组 | 32 | 5.46±1.73 | 461.79±194.06 | 3.81±2.73 | 33.0(15.5~210.0) | 5.34±1.85 | 1.09(0.68~2.64) |
组别 | 例数 | IL-1/ (pg/mL) | IL-2/ (pg/mL) | IL-6/ (pg/mL) | IL-8/ (pg/mL) | IL-10/ (pg/mL) | hs-CRP/ (mg/L) |
---|---|---|---|---|---|---|---|
DR继发性NVG组 | 37 | 5.22±1.20 | 402.10±147.54 | 3.25±2.52 | 21.5(13.3~144.5) | 5.09±0.52 | 1.05(0.68~2.67) |
RVO继发性NVG组 | 32 | 5.46±1.73 | 461.79±194.06 | 3.81±2.73 | 33.0(15.5~210.0) | 5.34±1.85 | 1.09(0.68~2.64) |
项目 | IOP | VCDR | CCT | ACD | AL | MD | MS |
---|---|---|---|---|---|---|---|
IL-1 | |||||||
r值 | 0.124 | 0.026 | 0.209 | 0.067 | 0.157 | 0.053 | 0.041 |
P值 | 0.346 | 0.862 | 0.178 | 0.676 | 0.354 | 0.800 | 0.847 |
IL-2 | |||||||
r值 | 0.111 | 0.070 | 0.165 | 0.188 | 0.028 | 0.173 | 0.169 |
P值 | 0.400 | 0.639 | 0.289 | 0.238 | 0.870 | 0.306 | 0.317 |
IL-6 | |||||||
r值 | 0.196 | 0.118 | 0.031 | 0.218 | 0.113 | 0.257 | 0.196 |
P值 | 0.130 | 0.426 | 0.895 | 0.172 | 0.504 | <0.001 | <0.001 |
IL-8 | |||||||
r值 | 0.187 | 0.078 | 0.058 | 0.208 | 0.171 | 0.194 | 0.185 |
P值 | 0.150 | 0.596 | 0.710 | 0.191 | 0.313 | 0.251 | 0.273 |
IL-10 | |||||||
r值 | 0.051 | 0.208 | 0.222 | 0.151 | 0.187 | 0.078 | 0.141 |
P值 | 0.694 | 0.157 | 0.147 | 0.621 | 0.267 | 0.646 | 0.404 |
hs-CRP | |||||||
r值 | 0.180 | 0.121 | 0.030 | 0.060 | 0.016 | 0.208 | 0.244 |
P值 | 0.164 | 0.413 | 0.845 | 0.709 | 0.925 | 0.216 | 0.145 |
项目 | IOP | VCDR | CCT | ACD | AL | MD | MS |
---|---|---|---|---|---|---|---|
IL-1 | |||||||
r值 | 0.124 | 0.026 | 0.209 | 0.067 | 0.157 | 0.053 | 0.041 |
P值 | 0.346 | 0.862 | 0.178 | 0.676 | 0.354 | 0.800 | 0.847 |
IL-2 | |||||||
r值 | 0.111 | 0.070 | 0.165 | 0.188 | 0.028 | 0.173 | 0.169 |
P值 | 0.400 | 0.639 | 0.289 | 0.238 | 0.870 | 0.306 | 0.317 |
IL-6 | |||||||
r值 | 0.196 | 0.118 | 0.031 | 0.218 | 0.113 | 0.257 | 0.196 |
P值 | 0.130 | 0.426 | 0.895 | 0.172 | 0.504 | <0.001 | <0.001 |
IL-8 | |||||||
r值 | 0.187 | 0.078 | 0.058 | 0.208 | 0.171 | 0.194 | 0.185 |
P值 | 0.150 | 0.596 | 0.710 | 0.191 | 0.313 | 0.251 | 0.273 |
IL-10 | |||||||
r值 | 0.051 | 0.208 | 0.222 | 0.151 | 0.187 | 0.078 | 0.141 |
P值 | 0.694 | 0.157 | 0.147 | 0.621 | 0.267 | 0.646 | 0.404 |
hs-CRP | |||||||
r值 | 0.180 | 0.121 | 0.030 | 0.060 | 0.016 | 0.208 | 0.244 |
P值 | 0.164 | 0.413 | 0.845 | 0.709 | 0.925 | 0.216 | 0.145 |
项目 | B值 | 标准误 | Wald值 | P值 | OR值(95%CI) |
---|---|---|---|---|---|
性别 | 1.532 | 0.821 | 3.482 | 0.062 | 4.628(0.926~23.135) |
年龄 | 0.024 | 0.028 | 0.725 | 0.394 | 0.977(0.925~1.031) |
收缩压 | 0.031 | 0.024 | 1.708 | 0.191 | 0.969(0.925~1.016) |
舒张压 | 0.016 | 0.026 | 0.382 | 0.537 | 1.016(0.966~1.069) |
BMI | 0.020 | 0.111 | 0.032 | 0.858 | 1.020(0.821~1.267) |
高血压 | 0.262 | 0.685 | 0.147 | 0.701 | 0.769(0.201~2.943) |
糖尿病 | 1.635 | 0.696 | 5.522 | 0.019 | 5.128(1.312~20.048) |
IL-1 | 0.219 | 0.246 | 0.689 | 0.407 | 1.245(0.742~2.090) |
IL-2 | 0.000 | 0.002 | 0.026 | 0.871 | 1.000(0.995~1.004) |
IL-6 | 1.493 | 0.666 | 5.027 | 0.025 | 4.443(1.207~16.40) |
IL-8 | 0.065 | 0.033 | 3.915 | 0.048 | 1.067(1.001~1.237) |
IL-10 | 0.170 | 0.458 | 0.138 | 0.711 | 1.185(0.483~2.096) |
hs-CRP | 1.357 | 0.603 | 5.061 | 0.024 | 3.886(1.191~12.683) |
项目 | B值 | 标准误 | Wald值 | P值 | OR值(95%CI) |
---|---|---|---|---|---|
性别 | 1.532 | 0.821 | 3.482 | 0.062 | 4.628(0.926~23.135) |
年龄 | 0.024 | 0.028 | 0.725 | 0.394 | 0.977(0.925~1.031) |
收缩压 | 0.031 | 0.024 | 1.708 | 0.191 | 0.969(0.925~1.016) |
舒张压 | 0.016 | 0.026 | 0.382 | 0.537 | 1.016(0.966~1.069) |
BMI | 0.020 | 0.111 | 0.032 | 0.858 | 1.020(0.821~1.267) |
高血压 | 0.262 | 0.685 | 0.147 | 0.701 | 0.769(0.201~2.943) |
糖尿病 | 1.635 | 0.696 | 5.522 | 0.019 | 5.128(1.312~20.048) |
IL-1 | 0.219 | 0.246 | 0.689 | 0.407 | 1.245(0.742~2.090) |
IL-2 | 0.000 | 0.002 | 0.026 | 0.871 | 1.000(0.995~1.004) |
IL-6 | 1.493 | 0.666 | 5.027 | 0.025 | 4.443(1.207~16.40) |
IL-8 | 0.065 | 0.033 | 3.915 | 0.048 | 1.067(1.001~1.237) |
IL-10 | 0.170 | 0.458 | 0.138 | 0.711 | 1.185(0.483~2.096) |
hs-CRP | 1.357 | 0.603 | 5.061 | 0.024 | 3.886(1.191~12.683) |
项目 | 曲线下面积(95%CI) | 最佳诊断值 | 敏感性/% | 特异性/% | P值 |
---|---|---|---|---|---|
IL-6 | 0.773(0.682~0.863) | 2.55 pg/mL | 65.57 | 87.18 | <0.001 |
IL-8 | 0.873(0.802~0.945) | 12.50 pg/mL | 85.25 | 80.49 | <0.001 |
hs-CRP | 0.760(0.666~0.854) | 0.375 mg/L | 98.36 | 67.05 | <0.001 |
联合检测 | 0.902(0.842~0.963) | 80.33 | 92.31 | <0.001 |
项目 | 曲线下面积(95%CI) | 最佳诊断值 | 敏感性/% | 特异性/% | P值 |
---|---|---|---|---|---|
IL-6 | 0.773(0.682~0.863) | 2.55 pg/mL | 65.57 | 87.18 | <0.001 |
IL-8 | 0.873(0.802~0.945) | 12.50 pg/mL | 85.25 | 80.49 | <0.001 |
hs-CRP | 0.760(0.666~0.854) | 0.375 mg/L | 98.36 | 67.05 | <0.001 |
联合检测 | 0.902(0.842~0.963) | 80.33 | 92.31 | <0.001 |
[1] | 阿依努尔·艾买尔,克力木江·阿不拉. 新生血管性青光眼患者血清和房水中IL-6、IL-8、TNF-α的表达水平及意义[J]. 国际眼科杂志,2018,18(8):1393-1396. |
[2] | 徐常钦,刘景祥. 细胞因子和新生血管性青光眼[J]. 吉林医学,2011,32(18):3783-3784. |
[3] | 赵明威. 新生血管性青光眼治疗面临的临床问题与思考[J]. 中华实验眼科杂志,2016,34(7):577-579. |
[4] | GOTO A,INATANI M,INOUE T,et al.Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy[J]. J Glaucoma,2013,22(7):572-576. |
[5] | 牛洁. TNF-α和IL-6在新生血管性青光眼发病过程中的作用[J]. 国际眼科杂志,2018,18(9):1684-1686. |
[6] | LI S,CAO W,SUN X.Role of platelet parameters on neovascular glaucoma:a retrospective case-control study in China[J]. PLoS One,2016,11(12):e0166893. |
[7] | 张春鸣,黄亮,李圣杰,等. 术前外周血血小板参数与原发性闭角型青光眼的相关性研究[J]. 中国眼耳鼻喉科杂志,2018,18(3):206-210. |
[8] | 李莉. 血清及房水中VEGF、IL-6水平与新生血管性青光眼的相关性研究[D]. 大连:大连医科大学,2011. |
[9] | FERRARA N,GERBER H P,LECOUTER J.The biology of VEGF and its receptors[J]. Nat Med,2003,9(6):669-676. |
[10] | 侯艳宏,崔红平. 新生血管性青光眼患者房水和血浆中VEGF、TGF-β1和IL-6的测定及意义[J]. 中华实验眼科杂志,2016,34(7):624-629. |
[11] | 凌佼佼,杨芳,洪斌,等. 血清及房水中VEGF、IL-6与新生血管性青光眼的相关性[J]. 海南医学,2017,28(23):3869-3871. |
[12] | CHEN K H,WU C C,ROY S,et al.Increased interleukin-6 in aqueous humor of neovascular glaucoma[J]. Invest Ophthalmol Vis Sci,1999,40(11):2627-2632. |
[13] | 白玉星,李静,田立艳,等. 新生血管性青光眼血清及房水IL-6、PEDF、VEGF水平变化[J]. 临床合理用药杂志,2015,8(7):171-172. |
[14] | 宋钊,庞婷婷,范右飞,等. IL-8与肺动脉高压大鼠血管重构和血管新生的关系[J]. 新医学,2013,44(7):508-512. |
[15] | GUJAM F J,GOING J J,MOHAMMED Z M,et al.Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer[J]. BMC Cancer,2014,14:676. |
[16] | 何乐,邹战明,乔金增,等. 内皮源IL-8对PCV2感染猪血管内皮细胞迁移的影响[J]. 北京农学院学报,2015,30(3):40-43. |
[17] | 费文君,袁丽萍,鹿玲,等. 鬼针草总黄酮对过敏性紫癜患儿血清IgA1诱导血管内皮细胞损伤的保护作用[J]. 中国中西医结合杂志,2016,36(2):183-187. |
[18] | 张勇,杨钦媚,郭凤,等. 慢性闭角型青光眼患者房水中炎症因子浓度升高[J]. 眼科,2017,26(4):229-233. |
[19] | 张勇,杨钦媚,郭凤,等. 基于Luminex液相芯片检测原发性开角型青光眼房水中多种细胞因子[J]. 眼科,2018,27(4):281-285. |
[20] | 李臻,王少杰,刘国立,等. 息肉状脉络膜血管病变患者房水中lL-8及其受体的表达[J]. 国际眼科杂志,2019,19(2):221-224. |
[1] | LI Dongxiu, HUANG Jian. Roles of serum sICAM-1 and hs-CRP levels in monitoring acute viral lower respiratory tract infection in children [J]. Laboratory Medicine, 2022, 37(3): 226-229. |
[2] | WANG Qian, ZHU Shiyao, LU Di, ZHU Kun, WU Jiong, QUAN Jiali. Arteriosclerotic cardiovascular disease risk markers research progress [J]. Laboratory Medicine, 2021, 36(4): 447-452. |
[3] | ZHAO Jingjing, ZHANG Peng, ZHOU Yong, CAO Yingping, HUANG Zhihu, FU Shengmiao, WANG Yuming, HONG Guolin, SHEN Jun, ZHENG Lei. A preliminary study on Lp-PLA2 and its relationship with LDL-C and hs-CRP in southern China [J]. Laboratory Medicine, 2021, 36(12): 1222-1228. |
[4] | HONG Weixiang, SONG Yunxiao, JIA Jiude, ZHANG Wentong, SHEN Wenhui, HUANG Jinwang, ZHANG Lei, SARI Jiang Yassen, ZHANG Yinwang. Association between serum IL-2R,IL-6 and IL-8 before treatment and postoperative 30 d prognosis of hip joint fracture in elderly patients [J]. Laboratory Medicine, 2021, 36(11): 1159-1163. |
[5] | ZHAO Minghai, LI Xin, WEI Dong, LUO Min, ZHANG Yajie, YANG Yiqi, ZHENG Lei. Influence of dry heat inactive treatment for the determination of inflammatory indicators related with corona virus disease 2019 [J]. Laboratory Medicine, 2020, 35(9): 924-927. |
[6] | YAO Tianyue, LI Jian, SONG Yunxiao, YUAN Wenhua, ZHAO Zhiyun, GE Wen. Correlation between interleukin and high-sensitivity C-reactive protein with primary angle-closure glaucoma [J]. Laboratory Medicine, 2020, 35(6): 583-586. |
[7] | ZENG Ruihuang, WANG Xiaolin, ZENG Ye, CHEN Zhixi, YUAN Ning, QIN Changhong. Roles of CA125,NLR,PLR and hs-CRP combined determination for community-acquired pneumonia with pleural effusion based on datum mining model [J]. Laboratory Medicine, 2020, 35(11): 1103-1107. |
[8] | MA Xiuqing, JIA Haiju, QIN Huiping, MA Huiying, YANG Xingtang, QI Yanxia, LI Shengmei, WANG Chunwei, HE Yujuan. Changes of IL-6 and other 7 indexes in patients with acute cerebral infarction in Qinghai [J]. Laboratory Medicine, 2019, 34(9): 821-825. |
[9] | GU Lei, YANG Yuqin, WANG Xia. PCT and hs-CRP determinations and the combined determination for the diagnosis of neonatal septicemia [J]. Laboratory Medicine, 2018, 33(7): 597-600. |
[10] | TANG Jun, LIN Jianbo. SAA and hs-CRP for the early diagnosis of infectious diseases in children [J]. Laboratory Medicine, 2018, 33(6): 499-502. |
[11] | YANG Yan, ZHANG Fujun, SHEN Songkun, WANG Houzhao. NT-proBNP,cTnI,Hcy,DD and hs-CRP for the diagnosis of coronary heart disease by ROC curves [J]. Laboratory Medicine, 2018, 33(1): 15-19. |
[12] | JIANG Wenli, JIN Peipei, REN Yiqian, SHEN Lisong. Correlation of the levels of coagulation factor ⅩⅢ and cytokines with stroke [J]. Laboratory Medicine, 2017, 32(6): 467-470. |
[13] | XIE Zejin, WANG Houzhao, LIN Yi. CD62p,IL-6 and hs-CRP levels in rheumatoid arthritis [J]. Laboratory Medicine, 2017, 32(11): 966-969. |
[14] | MU Yuejing, WANG Weijia, XU Shengnan, KAN Lijuan, HUANG Yanhua, OUYANG Nengliang, XU Quanzhong, YAN Haizhong, ZHANG Xiuming. Diagnostic significance on the dynamic monitoring of serum procalcitonin level for recurrent infection [J]. Laboratory Medicine, 2015, 30(9): 881-885. |
[15] | ZHOU Yunjiao, ZHANG Lihong, LI Peng, YE Xianwu, NIU Jianying. The variation and significance of IL-17 and IL-23 in adult patients with primary nephrotic syndrome [J]. , 2015, 30(6): 554-558. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||